Name
AtriCure
Company Description
AtriCure provides innovative technologies for the treatment of Afib and related conditions. The Isolator® Synergy™ Ablation System is FDA approved for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely sold LAA management devices worldwide, with more than 170,000 implanted.
Product Categories
Instrumentation, Interventional - Coronary
Address
7555 Innovation Way
Mason, OH 45040
United States